Stroke by mechanism of thrombotic cerebral ischemia is one of the leading causes of death and/or disability worldwide. Current research is under consensus that there are sex-based differences in both the prevalence and presentation of stroke and thrombosis. Here we discuss the interrelation between thrombosis and infl ammation and call attention to points in the cerebral ischemic cascade where estrogen may be involved in neuroprotection. Cerebral ischemia triggers a series of events including infl ammation, which is deeply interrelated with thrombosis; infl ammation not only produces local thrombosis, but thrombosis can also amplify infl ammation especially through the synergism of leukocyte and platelet activity. Research involving experimental animal models of cerebral ischemia has shown that sex hormones, especially estrogen, offer a degree of neuroprotection. Mechanisms of this neuroprotection may be linked to certain anti-infl ammatory properties of estrogen, as well as estrogen ' s regulation of thrombosis through the lowering of coagulation factors, among others. It is also understood that sex hormones alter the function and morphology of platelets and fi brin networks, and changes in platelet and fi brin network morphology offer one of the earliest confi rmations of infl ammation. Sex hormone levels, infl ammatory processes, and thrombotic mechanisms are profoundly interconnected in predicting the outcome of cerebral ischemia.
Introduction
Stroke is currently the second leading cause of death and/or disability worldwide, and the existence of a larger aging population suggests that stroke research will become more important in the future (Elkins and Johnston , 2003 ; Braeuninger and Kleinschnitz , 2009 ). Thrombotic cerebral ischemia accounts for more than half of all cases of stroke worldwide. It results from an occlusion of cerebral vasculature, reducing or preventing the supply of oxygen to the cerebrum, thus hampering metabolic demand, and ultimately leading to death of brain tissue by ischemic stroke.
Research suggests that there are sex-based differences in the prevalence and presentation of both stroke and thrombosis (Bailey et al. , 2009 ). Sex hormones not only alter procoagulant protein expression (Lowe et al. , 2004 ) and the function of blood and vascular cells (Kadir et al. , 1999 ; Butenas and Mann , 2002 ; Leng et al. , 2004 ), but differences in platelet function (Liao et al. , 2001 ; Suzuki et al. , 2009 ) and in thrombosis activity (Bailey et al. , 2009 ) have also been noted. Estrogen is to a degree neuroprotective (Liao et al. , 2001 ; Suzuki et al. , 2009 ; Selvamani and Sohrabji , 2010 ) in certain cases of induced cerebral ischemia, as females appear to suffer less severe consequences of stroke, including lesser neural tissue loss, than their male counterparts (McCullough and Hurn , 2003 ; Suzuki et al. , 2009 ). In the absence of ovarian hormone production at menopause, females are again at higher risk to strokes than their male counterparts, and this risk continues to increase with age, as women have a longer life expectancy than men (Mitka , 2006 ; Suzuki et al. , 2009 ). Thus, both sex and age play an important role in the occurrence of thrombotic events and the severity of neural damage subsequent to a stroke.
Platelets and fi brin play an important role in the normal coagulation process where they are involved in the maintenance of hemostasis (Herd and Page , 1994 ) . Their activation may be due to damage of the vessel wall or activation of the endothelium by chemicals, cytokines, and also infl ammatory processes (Camera et al. , 1999 ; Butenas and Mann , 2002 ) . Activated platelets synthesize/secrete inducers of platelet aggregation and adhere to the injured vessel wall, as well as aggregate to each other in order to form a platelet-rich plug or thrombus, which secures hemostasis; this plug is then stabilized by fi brin formation as fi brinogen is activated by binding to activated platelets. Fibrinogen is the major plasma protein coagulation factor (Lowe et al. , 2004 ) , and though plasma levels thereof are decreased by estrogen during the menstrual cycle, these levels are known to be higher in females than in males (Bailey et al. , 2009 ) . Although fi brin forms the core matrix of a thrombus, its structure depends also on the cellular elements embedded in its meshwork and the overall rate of coagulation reactions initiated by platelet aggregation (Wohner , 2008 ) . Morphological changes of fi brin networks may therefore occur due to several kinetic and modulating factors present in plasma.
A thrombotic event is associated with a change in hemostasis and cellular components that play a fundamental role in blood platelets and fi brin network formation. It is well known that thrombotic events are the most common cause of stroke and resultant cerebral ischemia (Braeuninger and Kleinschnitz , 2009 ). Furthermore, it is known that cerebral ischemia triggers a cascade of infl ammatory processes, among others (Herd and Page , 1994 ; Gibson et al. , 2005 ; Wang et al. , 2007 ) . Infl ammation again causes an alteration in platelet activation (Camera et al. , 1999 ; Butenas and Mann , 2002 ) and possibly further thrombotic events. It is suggested that estrogen provides neuroprotection through certain antiinfl ammatory mechanisms, among others (Vegeto et al. , 2008 ; Suzuki et al. , 2009 ).
Cerebral ischemia
With two-thirds of deaths from stroke complications occurring in developing regions of the world, such as sub-Saharan Africa, stroke is the second leading cause of death worldwide. The existence of a larger aging population suggests that stroke research will become more important in the future (Elkins and Johnston , 2003 ; Wang et al. , 2007 ; Braeuninger and Kleinschnitz , 2009 ) .
Stroke incidence and resultant cerebral ischemia can be linked to coagulation processes. The cascade of blood coagulation is initiated when subendothelial tissue factor is exposed to the fl ow of blood subsequent to damage or activation of the vessel endothelium by chemicals, cytokines, or infl ammatory processes (Butenas and Mann , 2002 ) . The formation of a thrombus at a site of vessel injury is thus a hemostatic process. A thrombotic event, however, is associated with a change in hemostasis and cellular components that play a fundamental role in blood platelet and fi brin network formation. Overactivity of any one component of the coagulation cascade can result in the formation of tight and rigid fi brin networks (Fatah et al. , 1992 ) , which can cause blockage of one or multiple cerebral blood vessels, resulting in cerebral ischemia.
Cerebral ischemia is known to trigger a series of complex events initiating with cerebral hypoperfusion and comprising bioenergetic failure of cellular components, excitotoxicity, oxidative stress, biphasic dysfunction of the blood-brain barrier, microvascular injury, hemostatic activation, infl ammation, and formation of edema, as well as apoptosis and ultimate necrosis of neuronal, glial, and endothelial cells. This cascade of events is dependent on variables, such as onset and duration of ischemia, effectiveness of reperfusion, and resultant infarct size or tissue loss (Danton and Dietrich , 2003 ; Gibson et al. , 2005 ; Brouns and De Deyn , 2009 ; Saenger and Christenson , 2010 ) .
Blood-brain barrier disruption in ischemic stroke appears to be dependent on the response to and aggressiveness of reperfusion. Increased permeability of the blood-brain barrier takes place within the fi rst 24 hours of an ischemic event, with further damage occurring 48 -72 hours after ischemia in the absence of suffi cient reperfusion (Saenger and Christenson , 2010 ) . Infl ammation itself is recognized as a key element of the pathological progression of ischemic stroke. The destructive or benefi cial nature of infl ammation seems to be dependent on the severity of ischemia. It is thus likely that early infl ammatory responses may potentiate ischemic injury, whereas late responses may be benefi cial to recovery and repair of ischemic lesions (Wang et al. , 2007 ) . Infl ammation and thrombosis are deeply interrelated, as not only can infl ammation produce local thrombosis, but thrombosis can also amplify infl ammation (Libby and Simon , 2001 ) .
Thrombosis
Thrombosis, the most common cause of stroke, is infl uenced by factors including endothelial injury, blood stasis or turbulent fl ow, and hypercoagulability of blood . Endothelial injury is the most common cause of hemostatic coagulation processes, and it is vital that these processes are understood. Endothelial damage to vasculature initiates a local infl ammatory response, promoting a state of prothrombosis, which is driven by tissue factor, adhesion molecules, and proinfl ammatory cytokines and prothrombotic microparticles (Libby and Simon , 2001 ) . Various disease states are also found to promote tissue factor exposure within vascular walls to blood fl ow, leading to the initiation of non-hemostatic coagulation processes (Mackman , 2004 ; Myers and Wakefi eld , 2005 ) . Thrombosis and infl ammation are interrelated (Stewart et al. , 1974 ; Myers and Wakefi eld , 2005 ) , as infl ammation produces local thrombosis, and thrombosis can amplify infl ammation (Libby and Simon , 2001 ) . A thrombus, whether formed through hemostatic or non-hemostatic mechanisms, consists of platelets and fi brin as well as trapped red and white blood cells, which stabilize its structure.
Platelets and fi brin play an important role in the coagulation process, where they are involved in the maintenance of hemostasis. Platelets have a life span of 8 -12 days, and though devoid of a nucleus, possess many features of classical infl ammatory cells. Like neutrophils, they can undergo chemotaxis (Zhang et al. , 1993 ) , phagocytose foreign particles, contain and release adhesive proteins, activate complement, interact with foreign bodies, alter vascular tone, enhance vascular permeability, as well as store and metabolize various vasoactive substances, and release infl ammatory mediators (Herd and Page , 1994 ) . Structurally, platelet surfaces consist of a typical bilayer membrane composed of lipids, proteins, and carbohydrates. Surface glycoproteins are essential to their function and play a primary role in their adhesion to exposed subendothelial matrix proteins, interaction with thrombin, and exposure of fi brinogen receptors to facilitate aggregation (Roth , 1992 ; Herd and Page , 1994 ) . Internally, platelets are only capable of limited protein synthesis, and few mitochondria are present, which contribute to energy metabolism of the platelet. In addition, a random cytoplasmic distribution of lysosomes, glycogen granules, and peroxisomes are present (Herd and Page , 1994 ) . Following activation, platelets change shape from a discoid to a spherical form. This process is mediated by a contractile microtubular system, morphologically characterized by an extension of dendritic pseudopodia (White , 1987 ; Herd and Page , 1994 ) .
Platelets are activated by a number of stimuli resulting in the expression and/or activation of surface receptors, secretion of vasoactive substances, adhesion, aggregation, and fi nally, thrombus formation. The activation may be due to damage of the vascular wall or activation of the endothelium by chemicals, cytokines, and also infl ammatory processes (Camera et al. , 1999 ; Butenas and Mann , 2002 ) . Upon activation, platelets cover the exposed subendothelial matrix and mediate additional platelet and leukocyte recruitment through the release of microparticles that mediate local leukocyte-leukocyte and leukocyte-endothelial cell interactions -mechanisms which play a role in both thrombosis and infl ammation (Wagner and Burger , 2003 ) . Platelets are essential in the initial stages of thrombus formation because they adhere and aggregate at sites of vascular wall injury and then serve as a surface for coagulation reactions; the overall rate of which determines the fi nal structure of fi brin (Wohner , 2008 ) . Thrombi thus form locally in a vessel when injury occurs or endothelial activation takes place -as a hemostatic mechanism to repair the insult. Platelets, during adhesion to endothelium, are activated and release proinfl ammatory cytokines that further stimulate the endothelium (Weber and Springer , 1997 ; Wagner and Burger , 2003 ) , promote hemoattraction of leukocytes, stimulate smooth muscle cell and fi broblast proliferation, promote collagen synthesis, and thus contribute directly to lesion progression and maturation (Ross , 1985 ; Wagner and Burger , 2003 ) .
Fibrinogen is the major plasma protein coagulation factor and the best known precursor of fi brin, playing an important role in platelet aggregation by linking activated platelets, and therefore playing a key role in hemostasis and thrombosis. Activated platelets synthesize/secrete inducers of platelet aggregation, adhere to the injured vessel wall, and aggregate to each other in order to form a platelet-rich plug that secures hemostasis; this plug is then stabilized by fi brin formation as fi brinogen is activated by binding to activated platelets. Thus, not all circulating fi brinogen is functional or clottable. As the tissue repair process takes place, the fi brin plug is digested by fi brinolytic enzymes (Lowe et al. , 2004 ) . On the one hand, low levels of plasma fi brinogen are associated with an increased risk for bleeding, as platelet aggregation as well as fi brin plug formation is impaired. Elevated fi brinogen levels, on the other hand, may well be associated with the risk of stroke (Danesh et al. , 2005 ) , as elevated fi brinogen synthesis is inclined to shift the hemostatic balance in favor of coagulation/thrombosis.
Interestingly, thrombi are found to form readily and rapidly in the complete absence of fi brinogen in animal models. However, these thrombi are unstable and fail to resist shear stress, resulting in frequent thromboembolization, with downstream vessel occlusion (Ni et al. , 2000 ; Wagner and Burger , 2003 ) . Fibrinogen/fi brin complexes are thus required to secure thrombus stability for anchorage to the site of injury. In addition, this stability is dependent on fi brinogen/fi brin interaction with platelet integrin (a surface protein), which also slows down the growth of the thrombus (Hawiger , 1995 ; Ni et al. , 2000 ; Wagner and Burger , 2003 ) . Fibronectin is known to support platelet adhesion and distribution (Hynes , 1990 ; Wagner and Burger , 2003 ) . Defi ciency of plasma fi bronectin though does not affect initial platelet adhesion (Sakai et al. , 2001 ; Wagner and Burger , 2003 ) , but delays thrombus formation quite substantially as platelets are continuously shed. Therefore, fi bronectin is an important mediator of plateletplatelet interactions within thrombi as they form and grow. This mediation takes place through fi bronectin ' s rapid binding to activated integrins, thus cross-linking platelets. Fibrin is then generated, which anchors the growing thrombus to the site of vascular injury (Ni et al. , 2000 ; Wagner and Burger , 2003 ) .
Platelet adhesion and activation are thus regulated by specifi c proteins on the platelet surface, and fi brinogen as well as fi bronectin plays a fundamental role in the coagulation process (Ni et al. , 2000 ; Lowe et al. , 2004 ) . Fibrin assembly (through the coagulation pathway and involvement of the platelets) from fi brinogen proceeds in a highly ordered fashion. Fibrin forms a network, which functions to stabilize the primary platelet plug. Although fi brin forms the core matrix of a thrombus, its structure depends also on the cellular elements embedded in its meshwork. Morphological changes of fi brin networks may therefore occur due to several kinetic and modulating factors present in plasma. Fibrinolysis plays an important role in hemostasis too. Leukocyte-derived enzymes, such as elastase, infl uence fi brinolysis by direct digestion of fi brin or indirectly modulating it by partial degradation of zymogens and inhibitors of coagulation and fi brinolytic proteases (Wohner , 2008 ) .
Thrombosis research has shown that sex hormones have complex effects on vascular walls, coagulation proteins, and platelets -all which may alter thrombosis. In line with this, females have shown cyclic patterns in their coagulation proteins, which correspond to menstrual cycle patterns (Kadir et al. , 1999 ; Bailey et al. , 2009 ) ; in addition, they possess slightly higher fi brinogen levels than their male counterparts, though estrogen is known to decrease fi brinogen plasma levels (Mendelsohn and Karas , 1999 ; Bailey et al. , 2009 ). There also seem to be sex-related differences in platelet function. It is known that isolated female platelets bind more fi brinogen and have a greater maximal aggregation extent than male platelet isolates, and this platelet reactivity is altered in ovariectomized females (Leng et al. , 2004 ; Bailey et al. , 2009 ) . Males have been shown to have higher platelet counts and faster clotting times than their female counterparts, thus making them more susceptible to thrombosis -possibly due to the differences in growth hormone secretion between the sexes (pulsatile in males, sustained in females), which in turn infl uence protein production of coagulation and thrombosis regulators (Wong et al. , 2008 ; Bailey et al. , 2009 ). Isolates of male rat platelets have been shown to display greater maximal aggregation in vitro than platelets isolated from female rats; this aggregation is reduced in male rats that have undergone castration (Emms and Lewis , 1985 ; Bailey et al. , 2009 ) . It has been noted that both megakaryocytes and platelets express the estrogen receptor beta (ER β ) as well as the androgen receptor (Jayachandran and Miller , 2003 ; Bailey et al. , 2009 ); thus, it is almost certain that the sex hormones have an effect on thrombosis. Estrogen is hypothesized to have a direct effect on platelet function, whereas androgen seems to regulate megakaryocyte biology and platelet production (Peters et al. , 2002 ; Bailey et al. , 2009 ) .
The occurrence of thrombosis is thus hemostasis in the wrong place, which results from local activation of platelets and coagulation, and also from increased concentrations of plasma fi brinogen (Lowe et al. , 2004 ) . As mentioned, females have elevated fi brinogen levels compared to their male counterparts, though estrogen does lower fi brinogen levels (Mendelsohn and Karas , 1999 ; Bailey et al. , 2009 ) , and in menopause, these plasma-lowering effects of estrogen are ruled out, rendering fi brinogen levels even higher than in cyclic females (Lowe et al. , 1997 (Lowe et al. , , 2004 . Many diseases like cancer, thrombotic disease, bleeding disorders, asthma, and even conditions like HIV/AIDS are associated with changes in platelet and fi brin structure. Fibrin structure itself has been shown to play a role in the development of vascular complications (Pretorius et al. 2006 (Pretorius et al. , 2007 .
Cerebral ischemia may be a consequence of thrombosis when a change in hemostasis occurs, for example, in the instance of a blood disorder or diminished blood fl ow (due to age or even normal thrombus formation), resulting in a local accumulation of coagulation factors and thus increasing platelet aggregation. These changes in hemostasis thus alter the coagulation cascade and result in the formation of rigid fi brin networks, which do not digest as programed. These rigid thrombi may cause ischemia locally if they diminish or inhibit the blood fl ow in a vessel for an extended period, or pieces thereof may break free, termed a thromboembolus, and become lodged in another vessel where they can cause ischemia by inhibition of blood fl ow.
Infl ammation
Infl ammation is characterized by interactions among endothelial cells, platelets, and leukocytes, and causes endothelial activation regardless of the mechanisms by which infl ammation itself was activated. Endothelial activation sets off the cell adhesion cascade, which results in the adherence and aggregation of platelets, chemokine deposition by platelets on the activated endothelial surface, the expression of cell adhesion molecules by endothelial cells and platelets, and ultimately, activation of leukocytes. Chemokines activate leukocytes, and further binding to adhesion molecules mediate the process of leukocyte rolling (on the activated ' sticky ' endothelium), adhesion (through binding to fi brinogen), and transmigration into the subendothelial tissue (Butcher , 1991 ; Springer , 1994 ; Diacovo et al. , 1996 ; Kuijper et al. , 1996 ; Weber and Springer , 1997 ; Konstantopoulos et al. , 1998 ; Wagner and Burger , 2003 ) . Platelets are thus central to both thrombosis and infl ammation.
The objective of infl ammation is therefore to recruit leukocytes rapidly to a site of vascular injury. Endothelial dysfunction or injury promotes activation of the coagulation cascade by exposure of tissue factor (Gimbrone , 1995 ; Day et al. , 2005 ; Myers and Wakefi eld , 2005 ) , as well as the activation of infl ammatory process (Laursen et al. , 2001 ; Altman , 2003 ; Myers and Wakefi eld , 2005 ) . Infl ammatory mediators then promote coagulation through further elevation of tissue factor (Drake et al. , 1989 ; Esmon , 2003 ) , which elevates fi brinogen synthesis, and fi brinogen levels will continue to rise under infl ammatory conditions (Taylor et al. , 1987 ; Esmon , 2003 ) unless hemostatic factors counteract this. Tissue factor is a membrane-bound protein that functions as a procoagulant (Libby and Simon , 2001 ), triggering thrombin generation, which then prompts activation of the coagulation cascade (Nemerson , 1988 ; Mann et al. , 1998 ; Myers and Wakefi eld , 2005 ) . Thrombin in turn amplifi es the infl ammatory response by activating the endothelium, resulting in the formation of more tissue factor (Pendurthi et al. , 1997 ; Miller et al. , 1998 ; Esmon , 2003 ) and high levels of platelet-activating factor (Bar -Shavit et al., 1986 ; Esmon , 2003 ) , which is a neutrophil agonist (Lorant et al. , 1991 ; Esmon , 2003 ) enhancing leukocyte activation and adhesion, as well as increasing infl ammatory cytokines (Henn et al. , 1998 ; Andr é et al., 2002 , Esmon , 2003 . Infl ammatory cytokines have been shown to increase platelet reactivity, which increases thrombogenic potential (Burstein , 1997 ; Esmon , 2003 ) , further linking infl ammation and thrombosis.
Monocytes do not express tissue factor unless they are stimulated by infl ammatory mediators to transcribe the gene for tissue factor (Wilcox et al. , 1989 ; Brand et al. , 1991 ; Libby and Simon , 2001 ); thus, their recruitment and activation can lead to thrombogenesis. Activated monocytes that express tissue factor on their surfaces (Rauch and Nemerson , 2000 ) facilitate monocyte-platelet and monocyte-endothelial interactions through binding mechanisms of cell adhesion molecules (Wakefi eld et al. , 1997 ; Shebuski and Kilgore , 2002 ; Myers and Wakefi eld , 2005 ) . These interactions, driven by infl ammatory mediators and tissue factor, lead to accelerated fi brin formation and deposition into a developing thrombus (Shebuski and Kilgore , 2002 ; Myers and Wakefi eld , 2005 ) . Thus, the specifi c interaction between cell adhesion molecules and their leukocyte receptors is what stimulates fi brin formation (Goel and Diamond , 2001 ; Myers and Wakefi eld , 2005 ) , and procoagulant microparticles derived both from activated leukocytes and platelets amplify the coagulation process (Frenette et al. , 2000 ; Myers and Wakefi eld , 2005 ) .
Like endothelial cells and activated monocytes, smooth muscle of blood vessels can express tissue factor when exposed through endothelial breakage, thus also contributing to thrombogenesis (Schecter et al. , 1997 ; Libby and Simon , 2001 ) . Besides production of procoagulant tissue factor, the smooth muscle can also undergo infl ammatory activation when exposed to thrombin and products of thrombosis (Kranzh ö fer et al., 1996 ; Libby and Simon , 2001 ) , thus amplifying the infl ammatory response and promoting systemic procoagulant effects due to increased fi brinogen levels in circulation (Libby and Simon , 2001 ) .
The progression of the infl ammatory response subsequent to a stimulus hence refl ects a balance between prothrombotic and anticoagulant activities. The ability of proinfl ammatory cytokines to downregulate antithrombotic proteins and upregulate prothrombotic proteins shifts this balance toward a procoagulant state (ten Cate et al. , 1997 ; Myers and Wakefi eld , 2005 ) ; in addition, these cytokines induce the immune defense mechanism and mediate leukocyte recruitment. Infl ammatory cells are important to the process of thrombus recanalization and organization. Although it may seem intuitive that a decrease in infl ammation will decrease thrombogenesis, once a clot forms, the presence of neutrophils is important for recanalization (Varma et al. , 2003 ; Myers and Wakefi eld , 2005 ) . Accordingly, infl ammation leads to an imbalance between the pro-and anticoagulant properties of endothelium that can lead to local stimulation of the coagulation cascade (Nathan , 2002 ; Wagner and Burger , 2003 ) . Early infl ammatory responses may consequently contribute to damage, whereas late/delayed infl ammatory responses are necessary to facilitate repair.
As mentioned previously, cerebral ischemia triggers infl ammatory processes (Herd and Page , 1994 ; Gibson et al. , 2005 ; Wang et al. , 2007 ) . The fi rst infl ammatory cells that enter the brain subsequent to trauma are neutrophils, followed by monocytes, and later on, resident microglia, astrocytes, and neurons are also activated (Morganti -Kossmann et al., 2001 ) . Leukocytes and, after a few hours post-injury, microglia secrete proinfl ammatory cytokines and chemokines, the severity of which play detrimental roles in the pathophysiology of stroke (Morganti -Kossmann et al., 2001 ; Wang et al. , 2007 ; Suzuki et al. , 2009 ) . Signifi cant leukocyte infl ux into cerebral parenchyma and tissue remodeling are characteristics of cerebral ischemia/reperfusion (Barone et al. , 1995 ; Wang et al. , 2007 ) . Interestingly, infarct volume has been shown to be reduced signifi cantly through the inhibition of neutrophil infi ltration, as it is evident that neutrophils wield the most damage to ischemic lesions once reperfusion is undertaken (Connolly et al. , 1996 ; Guha and Mackman , 2001 ; Wang et al. , 2007 ) .
In areas of ischemia/reperfusion injury, platelets colocalize with leukocytes -an interaction linking hemostatic thrombotic and infl ammatory responses (Ostrovsky et al. , 1998 ; Libby and Simon , 2001 ). The infl ammatory reaction subsequent to cerebral ischemia is characterized by neutrophil adherence to blood vessels 4 -6 hours after onset of ischemia and their infi ltration into the neural tissue with subsequent release of proinfl ammatory mediators, potentiating injury (Hallenbeck , 1996 ; Wang et al. , 2007 ) , by resultant accumulation and activation of monocytes in the area of lesion. Platelets promote accumulation of both neutrophils and monocytes at sites of injury, and neutrophil-platelet aggregates specifi cally infl uence cellular responses by inducing further leukocyte activation, enhancing cell-adhesion molecule expression, and generating signals that promote platelet integrin (surface protein) activation and chemokine synthesis (Ott et al. , 1996 ; Furman et al. , 1998 ; Libby and Simon , 2001 ) . Chemokines stimulate cytoskeletal reorganization of neutrophils and monocytes to facilitate their motility, proliferation of fi broblasts and astrocytes for glial scar formation, apoptosis and necrosis of neurons, and the phagocytic ability of macrophages and microglia to remove the debris of damaged tissue (Morganti -Kossmann et al., 2001 ).
Neuroprotection
Sex hormones target the central and peripheral nervous systems, affecting brain development and differentiation and infl uencing neuronal functions (Manthey and Behl , 2006 ; Dra č a, 2009 ). In humans, it is accepted that premenopausal or cyclic women present with a lower incidence of ischemic stroke than men; this distinction is, however, no longer present when postmenopausal or acyclic women are compared to men. Furthermore, the ischemic stroke risk increases in both sexes with age (Wolf , 1990 ; Gibson et al. , 2005 ; Braeuninger and Kleinschnitz , 2009 ). Thus, sex hormones must have a role in neuroprotection and the decline thereof with age.
Experimental animal studies have not only reported that young females present with smaller cerebral infarcts and thus less neural tissue injury than their male counterparts (Alkayed et al. , 1998 ; Braeuninger and Kleinschnitz , 2009 ), but also that high endogenous estradiol levels during the estrus cycle seem to correlate with smaller infarct size in females (Carswell et al. , 2000 ; Braeuninger and Kleinschnitz , 2009 ). This advantage is abolished in ovariectomized animals, due to the loss of endogenous female sex hormones (Simpkins et al. , 1997 ; Alkayed et al. , 1998 Alkayed et al. , , 2000 Hawk et al. , 1998 ; Liao et al. , 2001 ; Gibson et al. , 2005 ; Park et al. , 2006 ; Dra č a, 2009 ; Selvamani and Sohrabji , 2010 ) , and the consequences of cerebral ischemia in aged animals are more severe than in young animals (Davis et al. , 1995 ; Alkayed et al. , 1998 ) .
The female sex hormone 17 β -estradiol has been shown to be the principal circulating estrogen protecting the brain from damage, by reducing infarct size after experimental cerebral ischemia, through attenuation of markers of apoptosis by activation of mediators of cell survival signaling pathways. It seems that when administered several days before inducing cerebral ischemia, physiological levels of estradiol attenuate brain injury through the suppression of neuronal apoptosis and genomic actions by acting through mechanisms of the classical nuclear estrogen receptors (Liao et al. , 2001 ; Prewitt and Wilson , 2007 ; Jia et al. , 2009 ; Suzuki et al. , 2009 ) ; this is, however, not the case with acute administration of 17 β -estradiol at the time of injury, as this does not reduce the extent of infarction (Dubal et al. , 1998 ; Suzuki et al. , 2009 ) .
In studies of the neuroprotective extent of estradiol, researchers have shown that a single high-dose injection (1 mg/kg) of 17 β -estradiol administered to male rats immediately before experimental cerebral ischemia was capable of reducing cortical tissue loss, and that castration of male rats, resulting in the loss of testosterone, did not alter these results (Toung et al. , 1998 ) . Moreover, injection of exogenous 17 β -estradiol was only neuroprotective in the male brain, revealing that endogenous estrogen is suffi cient to protect the female brain and that exogenous 17 β -estradiol had no additional protective effect (Toung et al. , 1998 ) . Thus, the hypothesis that estrogen is a major mediator of sex differences displayed in stroke is heavily strengthened (Dra č a, 2009 ).
17 β -Estradiol salvages the brain from ischemic injury, even enhancing recovery and reducing infarct size in ovariectomized (Simpkins et al. , 1997 ; Selvamani and Sohrabji , 2010 ) and reproductively senescent or aged females (Alkayed et al. , 2000 ; Liao et al. , 2001 ) , as well as in male animals (Hawk et al. , 1998 ) . In the case of acyclic females, this is subject to administration of 17 β -estradiol at the onset of senescence or ovariectomy and not in older acyclic females (Bake and Sohrabji , 2004 ; Suzuki et al. , 2009 ; Selvamani and Sohrabji , 2010 ) . This seems to be due to the upregulation of estrogen receptor alpha (ER α ) close to the onset of senescence, in response to declining estrogenic stimuli from the ovaries, inadvertently providing a substrate for exogenous estrogen. However, in older acyclic females, the ER α is already downregulated, and thus, exogenous estrogen becomes deleterious (Jezierski and Sohrabji , 2001 ; Selvamani and Sohrabji , 2010 ) . Ischemic injury itself has been found to increase the expression of ER α in the cerebral cortex, without infl uencing ER β expression. Consequently, it is believed that it is this ER α re-expression after ischemic injury that mediates 17 β -estradiol ' s profound neuroprotection against ischemia (Dubal et al. , 2001 ; Suzuki et al. , 2007 Suzuki et al. , , 2009 .
Cerebral ischemia triggers a complex series of events, including excitotoxicity, infl ammation, and formation of edema, as well as apoptosis and necrosis (Danton and Dietrich , 2003 ; Gibson et al. , 2005 ; Saenger and Christenson , 2010 ) -all of which are reduced by estradiol through free radical scavenger action, among others (Demopoulos et al. , 1972 ; Singer et al. , 1996 ; Gibson et al. , 2005 ; Drač a, 2009 ) . Estradiol seems to target neural cells by indirect transcriptional mechanisms and by direct mechanisms, stabilizing neurotransmission, inhibiting apoptosis, reducing cerebral edema, and exerting anti-infl ammatory and antioxidant effects (Manthey and Behl , 2006 ; Dra č a, 2009 ) . Figure 1 proposes further points at which estradiol wields an infl uence in neuroprotection against cerebral ischemia.
Postischemic infl ammation strongly contributes to the extent of cerebral injury, and 17 β -estradiol may exert protection through anti-infl ammatory (Figure 1 ) actions (Vegeto et al. , 2008 ; Suzuki et al. , 2009 ) . In fact, the presence of initial neural infl ammation is negatively correlated with serum estradiol levels (Wang et al. , 2007 ) . The proposed antiinfl ammatory action of estradiol is strengthened by fi ndings that 17 β -estradiol is neuroprotective when administered immediately upon ovariectomy but not when administered after 10 weeks of hypoestrogenicity, demonstrating that a prolonged period of hypoestrogenicity disrupts not only the neuroprotective but also the anti-infl ammatory actions of estradiol (Suzuki et al., 2007 (Suzuki et al., , 2009 ). The fi rst cellular response in infl ammation is the activation and accumulation of neutrophils (Morganti -Kossmann et al., 2001 ) . It is evident in models of transient cerebral ischemia that tissue loss is reduced signifi cantly through the inhibition of neutrophil infi ltration, as it is apparent that neutrophils wield the most damage to ischemic lesions once reperfusion is undertaken (Connolly et al. , 1996 ; Guha and Mackman , 2001 ; Wang et al. , 2007 ) . It would seem that neutrophil accumulation is also negatively correlated with serum estradiol levels (Liao et al. , 2001 ) , strengthening evidence for the neuroprotective role of the female sex hormone even more. The anti-infl ammatory properties of 17 β -estradiol in the cerebral circulation thus infl uence the incidence, outcome, and severity of injury in stroke by attenuating ischemia-induced infl ammatory responses (Suzuki et al. , 2009 ) .
Not only does estradiol exert protective anti-infl ammatory actions subsequent to cerebral ischemia, but it also has a role in thrombosis (Figure 1 ) regulation (Wong et al. , 2008 ; Bailey et al. , 2009 ) , the alteration of which may result in cerebral ischemia. Coagulation factors and proteins are lowered by the presence of estrogen, though some factors (i.e., fi brinogen) are inherently higher in females than in males (Mendelsohn and Karas , 1999 ; Bailey et al. , 2009 ); in addition, there are cyclic patterns in these coagulation proteins that correspond to the menstrual cycle in females (Kadir et al. , 1999 ; Bailey et al. , 2009 ) . Functionally, female platelet isolates, though capable of binding more fi brinogen and displaying a greater maximal aggregation extent than male platelet isolates (Leng et al. , 2004 ; Bailey et al. , 2009 ), actually do not aggregate as quickly as the larger number of male platelets do, thus to some degree rendering females less susceptible to thrombosis. In the absence of estradiol in acyclicity, female platelets are again more susceptible to thrombosis (Wong et al. , 2008 ; Bailey et al. , 2009 ) . Platelets are indeed found to express ER β , which is hypothesized to have a direct effect on platelet function (Peters et al. , 2002 ; Jayachandran and Miller , 2003 ; Bailey et al. , 2009 ). Thus, it becomes clear that there are not only sex-based differences in coagulation processes but also age-based differences; as in a hypoestrogenic state, females not only have higher coagulation factors but also higher maximal platelet aggregation capabilities than males, rendering them more prone to thrombosis in an acyclic state.
Finally, it must be noted that estradiol replacement is not universally neuroprotective. It has been suggested that the neuroprotective effects of estrogen are more evident in transient than in permanent models of cerebral ischemia (Macrae and Carswell, 2006 ; Selvamani and Sohrabji , 2010 ) . This is suggested due to fi ndings that in severe ischemic injury, there are no sex differences in infarct size and also no reduction of the infarct with 17 β -estradiol administration (Vergouwen et al., 2000 ; Selvamani and Sohrabji , 2010 ) . Permanent ischemia leads to severe metabolic impairment in the cerebral cortex, which results in necrosis of many neurons in the region within several hours following injury. Regions surrounding the core of ischemia can be salvaged from apoptosis through the powerful neuroprotective action of 17 β -estradiol (Prewitt and Wilson , 2007 ; Suzuki et al. , 2009 ), but the effects of estradiol at the ischemic core are only visible in transient ischemic models. Conclusively, 17 β -estradiol protects the brain through suppression of neuronal apoptosis during the initial 24 hours after injury, in part by suppressing the infl ammatory response, and enhances neurogenesis within the fi rst 96 hours after ischemic stroke (Suzuki et al. , 2009 ).
Conclusions
Platelets are central to both thrombosis and infl ammation. Not only is platelet localization essential to thrombus initiation, formation, and stabilization, but in areas of ischemia/reperfusion injury in cerebral ischemia, platelets and leukocytes colocalize, linking hemostatic thrombotic and infl ammatory responses. Estrogen is neuroprotective in a myriad of mechanisms -a few of which include anti-infl ammatory actions and regulation of coagulation factors affecting thrombosis ability. The cascade of cerebral ischemia, its association to infl ammation and thrombosis, and their connection to each other are thus intricately intertwined.
